Tag Archives: Cannabis (Cannabis sativa

Regulatory Framework for the Expanding US Cannabis Industry Proposed in HerbalGram Article

Austin, TX (July 23, 2019). The current issue of the nonprofit American Botanical Council’s (ABC’s) peer-reviewed journal HerbalGram features a proposed state-federal regulatory framework for the US cannabis (Cannabis sativa) industry.1 The proposal suggests the removal of cannabis from the Controlled Substances Act (CSA), thus allowing US stakeholders entry into the global market. The US state-led regulated hemp and cannabis industry is valued at more

Read more

Cannabis Alleviates Anxiety, Depression and Pain in Patients Newly Diagnosed with Head and Neck Cancer

In October 2018, Canada became the third nation, and the world’s largest to date, to legalize adult (“recreational”) use of cannabis (marijuana; Cannabis sativa, Cannabaceae). While hinting at this development, the authors write that cannabis is “one of the most widely used illicit substance in Canada, [with] a unique ability to facilitate relaxation and relieve anxiety while reducing pain.”* Cancer diagnosis

Read more

Cannabinoids for Chemotherapy-induced Nausea and Vomiting: Overview of Systematic Reviews

Chemotherapy-induced nausea and vomiting (CINV), one of the most distressing chemotherapy-related adverse events (AEs), affects about 75% of patients undergoing chemotherapy. Antiemetic drugs are considered first-line treatments, while cannabinoids are considered an option to be used if other antiemetics fail. The cannabinoids used for CINV include tetrahydrocannabinol (THC) and analogs of THC. The US Food and Drug Administration (FDA) approved

Read more

Cannabis: Answer to The Opioid Crisis?

Opioid drugs* like oxycodone, hydrocodone, methadone, and heroin caused over 28,000 deaths in the United States in 2014, more than any earlier year on record, according to the Centers for Disease Control and Prevention (CDC). It was estimated in 2012 that about 2.1 million Americans suffered substance abuse disorders related to prescribed opioids and another half million were addicted to

Read more

Breeding Cannabis Chemovars for Patients Requiring Distinct Chemical Profiles for Optimum Efficacy

Proper exposition requires definition, certainly the case in the longstanding debate over cannabis (Cannabis sativa, Cannabaceae) speciation. Authors briefly introduce the ongoing dispute between followers of Fuchs (1542 CE) and Linnaeus (1753) and those of Lamarck (1783) and Schultes (1974). Lamarck described the putative “C. indica” and has been followed by proposed “compromise” naming like “C. afghanica,’ “C. ruderalis,” etc.

Read more

Administration and Dosing of Medical Cannabis

Despite centuries of medical use and several modern studies, 80 years of cannabis (Cannabis sativa, Cannabaceae) prohibition have left clinicians undereducated about its therapeutic uses. A 2017 US study found that 89.5% of surveyed residents and fellows felt unprepared to prescribe cannabis and just 35.5% felt prepared to answer patients’ questions about it. Only 9% of US medical schools include

Read more

Study Finds Cannabidiol Reduces Frequency of Convulsive Seizures in Children and Young Adults with Dravet Syndrome

Dravet syndrome, a rare genetic childhood epilepsy associated with drug-resistant seizures and high mortality, may be amenable to treatment with cannabidiol (CBD), a constituent of cannabis (Cannabis sativa, Cannabaceae). While 4 small trials reported mixed results, in vitro and in vivo models show antiseizure activity. A standardized oral solution of CBD (prepared and provided by GW Pharmaceuticals; London, United Kingdom)

Read more